Michael Mehan

Michael Mehan is the Director of Bioinformatics at Illumina, where he leads the Multiomics Bioinformatics group. His expertise lies in developing algorithms and software for innovations in epigenomics, transcriptomics, and proteomics. He holds a PhD in Molecular and Computational Biology from the University of Southern California and a B. S. from UCLA.

Based on his long-standing educational ties to Southern California, he likely follows local college sports. He has built his entire career within Illumina, progressing from a Senior Bioinformatics Scientist to his current Director-level position, showing significant company loyalty and professional growth.

Unique fact: Michael has conducted significant research on identifying blood protein signatures for the early detection of non-small cell lung cancer.